Synthesis and Pharmacological Evaluation of Novel GABAA Subtype Receptor Ligands with Potential Anxiolytic-like and Anti-hyperalgesic Effect

被引：5

作者：

Guerrini, Gabriella ^{[1
]}

Ciciani, Giovanna ^{[1
]}

Crocetti, Letizia ^{[1
]}

Daniele, Simona ^{[3
]}

Ghelardini, Carla ^{[2
]}

Giovannoni, Maria Paola ^{[1
]}

Mannelli, Lorenzo Di Cesare ^{[2
]}

Martini, Claudia ^{[3
]}

Vergelli, Claudia ^{[1
]}

机构：

[1] Univ Firenze, Dipartimento NEUROFARBA, Sez Farmaceut Nutraceut, Florence, Italy

[2] Univ Firenze, Dipartimento NEUROFARBA, Sez Farmacol, Florence, Italy

[3] Univ Pisa, Dipartimento FARM, Pisa, Italy

来源：

JOURNAL OF HETEROCYCLIC CHEMISTRY | 2017年 / 54卷 / 05期

关键词：

BENZODIAZEPINE-RECEPTOR; PAIN; RAT; MODULATION; EFFICACY; ACID;

D O I：

10.1002/jhet.2882

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The identification of selective benzodiazepine site ligands, endowed with anxiolytic and anti-hyperalgesic action, is a relevant opportunity for the treatment of pain syndromes. Previously, we selected a compound with a promising anti-hyperalgesic profile, the 3-iodo-8-benzylaminopyrazolo [5,1-c][1,2,4]benzotriazine 5-oxide. Aimed to verify the structure-activity relationship, the corresponding 7-arylakylamino derivatives were synthesized. Compounds were tested for their affinity at GABA(A)-receptor subtype; the compound 12 was further investigated in animal models of anxiety and persistent pain.

引用

页码：2788 / 2799

页数：12

共 50 条

[41] Design, synthesis, in silico, and pharmacological evaluation of novel quinoline derivatives containing substituted piperazine moieties as potential anti-breast cancer agents
Priya, Muthiah Gnana Ruba
Solomon, Viswas Raja
Hemavathy, Nagarajan
Jeyakanthan, Jeyaraman
Kumar, Dileep
Mahesh, Jahnavi
RESULTS IN CHEMISTRY, 2024, 7
[42] NOVEL 2-SUBSTITUTED-5-(4-CHLORO-2-PHENOXY)PHENYL-1,3,4-OXADIAZOLE DERIVATIVES, LIGANDS OF GABAA/BENZODIAZE- PINE RECEPTOR COMPLEX: DESIGN, SYNTHESIS, RADIOLIGAND BINDING ASSAY, AND PHARMACOLOGICAL EVALUATION
Rezaee, Elham
Ahmadi, Fatemeh
Shabaninia, Mahsa
Khoramjouy, Mona
Farsani, Zahra Azizi
Shahhosseini, Soraya
Tabatabai, Sayyed Abbas
Faizi, Mehrdad
EXCLI JOURNAL, 2022, 22 : 250 - 262
[43] Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity
Czopek, Anna
Byrtus, Hanna
Kolaczkowski, Marcin
Pawlowski, Maciej
Dybala, Malgorzata
Nowak, Gabriel
Tatarczynska, Ewa
Wesolowska, Anna
Chojnacka-Wojcik, Ewa
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (04) : 1295 - 1303
[44] Synthesis and pharmacological evaluation of new arylpiperazines.: 3-{4-[4-(3-chlorophenyl)-1-piperazinyl]butyl}-quinazolidin-4-one -: A dual serotonin 5-HT1A/5-HT2A receptor ligand with an anxiolytic-like activity
Bojarski, AJ
Kowalski, P
Kowalska, T
Duszynska, B
Charakchieva-Minol, S
Tatarczynska, E
Klodzinska, A
Chojnacka-Wójcik, E
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (12) : 3817 - 3827
[45] Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease
Yahiaoui, Samir
Hamidouche, Katia
Ballandonne, Celine
Davis, Audrey
Santos, Jana Sopkova de Oliveira
Freret, Thomas
Boulouard, Michel
Rochais, Christophe
Dallemagne, Patrick
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 : 283 - 293
[46] Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile
Canale, Vittorio
Rak, Aleksandra
Kotanska, Magdalena
Knutelska, Joanna
Siwek, Agata
Bednarski, Marek
Nowinski, Leszek
Zygmunt, Malgorzata
Koczurkiewicz, Paulina
Pekala, Elzbieta
Sapa, Jacek
Zajdel, Pawel
MOLECULES, 2018, 23 (09):
[47] Novel 3-aroylpyrazolo[ 5,1-c][1,2,4] benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex:: Synthesis, pharmacological and molecular modeling studies
Guerrini, Gabriella
Ciciani, Giovanna
Cambi, Giovanni
Bruni, Fabrizio
Selleri, Silvia
Melani, Fabrizio
Montali, Marina
Martini, Claudia
Ghelardini, Carla
Norcini, Monica
Costanzo, Annarella
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (08) : 4471 - 4489
[48] Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases
da Silva Cunha, Thayssa Tavares
Silva, Rafaela Ribeiro
Rodrigues, Daniel Alencar
Murteira Pinheiro, Pedro de Sena
Kronenberger, Thales
Sant'Anna, Carlos Mauricio R.
Noel, Francois
Manssour Fraga, Carlos Alberto
BIOMOLECULES, 2022, 12 (08)
[49] Aminobenzimidazoles and structural isomers: Design, synthesis, pharmacological evaluation and computational studies of novel dual-acting butyrylcholinesterase inhibitors and hCB2 receptor ligands for the treatment of Alzheimer's disease
Dolles, Dominik
Sawatzky, Edgar
Moeller, Jan
Nabissi, Massimo
Drakopoulos, Antonios
Strasser, Andrea
Wittmann, Hans-Joachim
Lohse, Martin
Decker, Michael
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[50] Discovery of new anti-depressants from structurally novel 5-HT3 receptor antagonists: Design, synthesis and pharmacological evaluation of 3-ethoxyquinoxalin-2-carboxamides
Mahesh, Radhakrishnan
Devadoss, Thangaraj
Pandey, Dilip Kumar
Bhatt, Shvetank
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (04) : 1253 - 1256

← 1 2 3 4 5 →